Related Experiment Video

Updated: Oct 1, 2026

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

The potential use of anti-enteroviral drugs in the immunocompromised

David Webster1

  • 1Department of Immunology, Royal Free Hospital, London, UK.

Current Opinion in Infectious Diseases
|April 20, 2002
PubMed

Insights

Enteroviral infection therapy is advancing, with pleconaril showing promise in clinical trials. Antibody-deficient patients serve as a key model for evaluating new antiviral drugs for chronic infections.

Area of Science:

  • Virology
  • Infectious Diseases
  • Pharmacology

Background:

  • Enteroviral infections pose a significant health challenge, particularly for antibody-deficient individuals who are susceptible to chronic infections.
  • Existing therapeutic options for enteroviral infections are limited, necessitating the development of novel antiviral compounds.
  • The diversity of enteroviral strains complicates traditional approaches like immunization and immunotherapy.

Purpose of the Study:

  • To review the current landscape of enteroviral infection therapy.
  • To highlight the role of pleconaril as a promising antiviral agent.
  • To discuss the utility of antibody-deficient patients as a model for studying chronic enteroviral infections and evaluating new drugs.

Main Methods:

  • Review of clinical trial data for pleconaril.
  • Analysis of the challenges in treating chronic enteroviral infections.
  • Discussion of potential therapeutic strategies, including combination drug therapy.

Main Results:

  • Pleconaril has demonstrated success in clinical trials, indicating its therapeutic potential.
  • Antibody-deficient patients provide a valuable model for assessing the efficacy of antiviral therapies against chronic enteroviral infections.
  • The development of new antiviral compounds is ongoing, with future clinical applications anticipated.

Conclusions:

  • Antiviral therapy for enteroviral infections is becoming a reality, with pleconaril as a leading example.
  • Combination drug therapy is likely to be the most effective strategy for managing chronic enteroviral infections.
  • Further research and clinical trials are essential to expand therapeutic options for these infections.

More Related Videos

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation08:04

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 9, 2014

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...